Home » IAS: Novel HIV Drug Looks Promising
IAS: Novel HIV Drug Looks Promising
The investigational next-generation non-nucleoside reverse transcriptase inhibitor lersivirine controls HIV as well as standard-care efavirenz (Sustiva) in treatment-naive patients, researchers said.
MedPage Today
MedPage Today
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May